FDA approves generic AZT for U.S. market.
O'Rourke
Matthew
M
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D040541:Marketing; D018894:Reverse Transcriptase Inhibitors; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine